Geoffrey Thomas Gibney

9PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingGene expression (incl. microarray and other genome-wide approaches)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 16, 2026
Stepping on the Gas or Hitting the Brakes: Response-Driven Therapy for Melanoma.

|Jul 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

|Mar 18, 2025
Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma.

Galina Lagos, Roman Groisberg, Andrew Elliott

|Dec 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.

Pamela Munster, Nicholas Iannotti, Daniel C Cho

|Oct 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.

Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder

Pageof 2